Operaciones Illumina Inc - ILMN CFD
Agregar a Favoritos- Resumen
- Datos históricos
- Eventos
- Cuenta de resultados
- Balance de situación
- Flujo de caja
- Propiedad
Condiciones de trading
| Diferencial | 1.18 | ||||||||
|
Tarifa nocturna posición alcista
Long position overnight fee
Ir a la plataforma | -0.030779% | ||||||||
|
Tarifa nocturna posición bajista
Short position overnight fee
Ir a la plataforma | -0.013666% | ||||||||
| Horario tarifa nocturna | 22:00 (UTC) | ||||||||
| Cantidad comercializada mínima | 1 | ||||||||
| Divisa | USD | ||||||||
| Margen | 20% | ||||||||
| Mercado de valores | United States of America | ||||||||
| Comisión por operación | 0% |
*Information provided by Capital.com
Illumina Inc ESG Risk Ratings
High Medium Low Negligible
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Estadísticas clave
| Cierre previo* | 208.56 |
| Abrir* | 205.59 |
| Cambio de 1 año* | -43.13% |
| Rango del día* | 205.59 - 216.11 |
| Rango de 52 semanas | 173.45-371.16 |
| Volumen medio (10 días) | 987.66K |
| Volumen medio (3 meses) | 24.06M |
| Capitalización de mercado | 32.83B |
| Ratio P/E | -100.00K |
| Acciones en circulación | 157.30M |
| Ingresos | 4.70B |
| EPS | -26.46 |
| Dividendo (Rendimiento %) | N/A |
| Beta | 1.14 |
| Próxima fecha de resultados | May 3, 2023 |
"Todos los datos son proporcionados por Refinitiv, excepto los datos marcados con un asterisco, que son *datos proporcionados por Capital.com"
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Cierre | Change | Change (%) | Apertura | High | Low |
|---|---|---|---|---|---|---|
| Feb 7, 2023 | 214.99 | 7.88 | 3.80% | 207.11 | 217.39 | 205.36 |
| Feb 6, 2023 | 208.56 | -1.72 | -0.82% | 210.28 | 212.44 | 205.05 |
| Feb 3, 2023 | 214.17 | -5.51 | -2.51% | 219.68 | 220.98 | 212.65 |
| Feb 2, 2023 | 224.67 | 6.15 | 2.81% | 218.52 | 225.28 | 215.72 |
| Feb 1, 2023 | 216.12 | 5.51 | 2.62% | 210.61 | 217.50 | 207.94 |
| Jan 31, 2023 | 214.00 | 4.87 | 2.33% | 209.13 | 214.33 | 208.89 |
| Jan 30, 2023 | 209.95 | 2.26 | 1.09% | 207.69 | 213.97 | 207.69 |
| Jan 27, 2023 | 213.81 | 4.68 | 2.24% | 209.13 | 214.90 | 206.56 |
| Jan 26, 2023 | 212.57 | 0.71 | 0.34% | 211.86 | 214.95 | 209.51 |
| Jan 25, 2023 | 210.75 | 2.76 | 1.33% | 207.99 | 211.78 | 204.96 |
| Jan 24, 2023 | 215.07 | 0.92 | 0.43% | 214.15 | 217.89 | 212.09 |
| Jan 23, 2023 | 216.12 | 12.49 | 6.13% | 203.63 | 216.55 | 202.39 |
| Jan 20, 2023 | 204.12 | 7.97 | 4.06% | 196.15 | 204.69 | 193.87 |
| Jan 19, 2023 | 196.19 | -7.13 | -3.51% | 203.32 | 205.72 | 195.96 |
| Jan 18, 2023 | 205.62 | -1.94 | -0.93% | 207.56 | 212.03 | 203.70 |
| Jan 17, 2023 | 206.23 | 5.70 | 2.84% | 200.53 | 206.45 | 196.95 |
| Jan 13, 2023 | 200.81 | 10.86 | 5.72% | 189.95 | 201.53 | 189.71 |
| Jan 12, 2023 | 193.65 | -7.04 | -3.51% | 200.69 | 202.53 | 189.27 |
| Jan 11, 2023 | 203.81 | 6.79 | 3.45% | 197.02 | 204.44 | 193.97 |
| Jan 10, 2023 | 194.39 | 9.69 | 5.25% | 184.70 | 199.41 | 180.82 |
Illumina Inc Events
| Time (UTC) | Country | Event |
|---|---|---|
| No events scheduled | ||
- Anual
- Trimestral
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Ingresos totales | 2398.37 | 2752 | 3333 | 3543 | 3239 | 4526 |
| Ingresos | 2398.37 | 2752 | 3333 | 3543 | 3239 | 4526 |
| Coste de los ingresos, total | 731.925 | 908 | 1033 | 1076 | 1036 | 1372 |
| Beneficio bruto | 1666.45 | 1844 | 2300 | 2467 | 2203 | 3154 |
| Gastos totales de explotación | 1811.34 | 2146 | 2450 | 2504 | 2659 | 4649 |
| Gastos de venta/general/administración Gastos, total | 583.005 | 674 | 794 | 835 | 941 | 2092 |
| Investigación y desarrollo | 504.415 | 541 | 623 | 647 | 682 | 1185 |
| Gastos (ingresos) extraordinarios | -8.004 | 23 | 0 | -54 | ||
| Ingresos de explotación | 587.032 | 606 | 883 | 1039 | 580 | -123 |
| Ingresos por intereses (gastos), netos No operativos | -23.382 | 435 | 8 | 75 | 237 | 919 |
| Otros, netos | -2.472 | 2 | 3 | 4 | 39 | 88 |
| Ingresos netos antes de impuestos | 561.178 | 1043 | 894 | 1118 | 856 | 884 |
| Ingresos netos después de impuestos | 428.09 | 828 | 793 | 990 | 656 | 762 |
| Intereses menores | 34.559 | 48 | 44 | 12 | 0 | |
| Beneficio neto antes de partidas extra. Elementos | 462.649 | 876 | 837 | 1002 | 656 | 762 |
| Ingresos netos | 462.649 | 726 | 826 | 1002 | 656 | 762 |
| Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | 462.649 | 876 | 837 | 1002 | 656 | 762 |
| Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | 462.649 | 726 | 826 | 1002 | 656 | 762 |
| Beneficio neto diluido | 462.649 | 726 | 826 | 1002 | 656 | 762 |
| Promedio ponderado de acciones diluidas | 148.04 | 148 | 149 | 149 | 148 | 151 |
| BPA diluido sin partidas extraordinarias | 3.12516 | 5.91892 | 5.61745 | 6.72483 | 4.43243 | 5.04636 |
| Dividends per Share - Common Stock Primary Issue | 0 | |||||
| BPA normalizado diluido | 3.08392 | 6.04229 | 5.61745 | 6.40391 | 4.43243 | 5.04636 |
| Total de partidas extraordinarias | -150 | -11 |
| Q1 2021 | Q2 2021 | Q3 2021 | Q4 2022 | Q1 2022 | |
|---|---|---|---|---|---|
| Ingresos totales | 1093 | 1126 | 1108 | 1199 | 1223 |
| Ingresos | 1093 | 1126 | 1108 | 1199 | 1223 |
| Coste de los ingresos, total | 329 | 324 | 338 | 382 | 408 |
| Beneficio bruto | 764 | 802 | 770 | 817 | 815 |
| Gastos totales de explotación | 900 | 939 | 1653 | 1158 | 1039 |
| Gastos de venta/general/administración Gastos, total | 374 | 413 | 879 | 426 | 308 |
| Investigación y desarrollo | 197 | 202 | 436 | 350 | 323 |
| Ingresos de explotación | 193 | 187 | -545 | 41 | 184 |
| Ingresos por intereses (gastos), netos No operativos | -64 | -12 | 931 | 64 | -50 |
| Otros, netos | 40 | 32 | 34 | -19 | 6 |
| Ingresos netos antes de impuestos | 169 | 207 | 420 | 86 | 140 |
| Ingresos netos después de impuestos | 147 | 185 | 317 | 112 | 86 |
| Beneficio neto antes de partidas extra. Elementos | 147 | 185 | 317 | 112 | 86 |
| Ingresos netos | 147 | 185 | 317 | 112 | 86 |
| Ingresos disponibles para los accionistas, excluyendo las partidas extra. Elementos | 147 | 185 | 317 | 112 | 86 |
| Ingresos disponibles para los accionistas, incluidos los elementos extra. Elementos | 147 | 185 | 317 | 112 | 86 |
| Beneficio neto diluido | 147 | 185 | 317 | 112 | 86 |
| Promedio ponderado de acciones diluidas | 147 | 147 | 153 | 157 | 159 |
| BPA diluido sin partidas extraordinarias | 1 | 1.2585 | 2.0719 | 0.71338 | 0.54088 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| BPA normalizado diluido | 1 | 1.2585 | 2.0719 | 0.71338 | 0.54088 |
- Anual
- Trimestral
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Total Activo Corriente | 2318.09 | 2980 | 4490 | 4451 | 4483 | 2713 |
| Efectivo e inversiones a corto plazo | 1558.72 | 2145 | 3512 | 3414 | 3472 | 1339 |
| Efectivo y Equivalentes | 734.516 | 1225 | 1144 | 2042 | 1810 | 1232 |
| Inversiones a corto plazo | 824.208 | 920 | 2368 | 1372 | 1662 | 107 |
| Total deudores, neto | 381.316 | 411 | 514 | 573 | 487 | 648 |
| Accounts Receivable - Trade, Net | 380.93 | 411 | 514 | 573 | 487 | 648 |
| Total Inventory | 300.17 | 333 | 386 | 359 | 372 | 431 |
| Prepaid Expenses | 77.881 | 91 | 78 | 105 | 152 | 295 |
| Total Assets | 4280.6 | 5257 | 6959 | 7316 | 7585 | 15217 |
| Property/Plant/Equipment, Total - Net | 713.334 | 931 | 1075 | 1444 | 1454 | 1696 |
| Property/Plant/Equipment, Total - Gross | 1040.15 | 1347 | 1596 | 2012 | 2132 | 2492 |
| Accumulated Depreciation, Total | -326.813 | -416 | -521 | -568 | -678 | -796 |
| Goodwill, Net | 775.995 | 771 | 831 | 824 | 897 | 7113 |
| Intangibles, Net | 242.652 | 175 | 185 | 145 | 142 | 3250 |
| Other Long Term Assets, Total | 230.528 | 400 | 378 | 452 | 609 | 445 |
| Total Current Liabilities | 704.665 | 746 | 1804 | 665 | 1244 | 1093 |
| Accounts Payable | 137.93 | 160 | 184 | 149 | 192 | 332 |
| Accrued Expenses | 392.296 | 376 | 256 | 263 | 287 | 429 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 1.25 | 10 | 1107 | 0 | 511 | 0 |
| Other Current Liabilities, Total | 173.189 | 200 | 257 | 253 | 254 | 332 |
| Total Liabilities | 2083.37 | 2508 | 3201 | 2703 | 2891 | 4477 |
| Total Long Term Debt | 1047.81 | 1182 | 890 | 1141 | 673 | 1695 |
| Long Term Debt | 1047.81 | 1182 | 890 | 1141 | 673 | 1695 |
| Minority Interest | 116.946 | 220 | 148 | 0 | ||
| Other Liabilities, Total | 213.955 | 360 | 359 | 897 | 974 | 1689 |
| Total Equity | 2197.23 | 2749 | 3758 | 4613 | 4694 | 10740 |
| Common Stock | 1.887 | 2 | 2 | 2 | 2 | 2 |
| Additional Paid-In Capital | 2733.39 | 2833 | 3290 | 3560 | 3815 | 8938 |
| Retained Earnings (Accumulated Deficit) | 1485.41 | 2256 | 3083 | 4067 | 4723 | 5485 |
| Treasury Stock - Common | -2022.43 | -2341 | -2616 | -3021 | -3848 | -3702 |
| Unrealized Gain (Loss) | -2.326 | -2 | -2 | 4 | 1 | |
| Other Equity, Total | 1.289 | 1 | 1 | 1 | 1 | 17 |
| Total Liabilities & Shareholders’ Equity | 4280.6 | 5257 | 6959 | 7316 | 7585 | 15217 |
| Total Common Shares Outstanding | 146.196 | 147 | 147 | 147 | 146 | 157 |
| Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 |
| Apr 2021 | Jul 2021 | Oct 2021 | Jan 2022 | Apr 2022 | |
|---|---|---|---|---|---|
| Total Activo Corriente | 5642 | 5310 | 2451 | 2713 | 2755 |
| Efectivo e inversiones a corto plazo | 4630 | 4286 | 1265 | 1339 | 1416 |
| Efectivo y Equivalentes | 4433 | 4196 | 1080 | 1232 | 1351 |
| Inversiones a corto plazo | 197 | 90 | 185 | 107 | 65 |
| Total deudores, neto | 517 | 540 | 604 | 648 | 630 |
| Accounts Receivable - Trade, Net | 517 | 540 | 604 | 648 | 630 |
| Total Inventory | 364 | 380 | 401 | 431 | 465 |
| Prepaid Expenses | 131 | 104 | 181 | 295 | 244 |
| Total Assets | 8755 | 8675 | 15063 | 15217 | 15274 |
| Property/Plant/Equipment, Total - Net | 1444 | 1481 | 1685 | 1696 | 1740 |
| Goodwill, Net | 897 | 966 | 7098 | 7113 | 7113 |
| Intangibles, Net | 134 | 162 | 3351 | 3250 | 3209 |
| Other Long Term Assets, Total | 638 | 756 | 478 | 445 | 233 |
| Total Current Liabilities | 1268 | 874 | 914 | 1093 | 1490 |
| Accounts Payable | 178 | 200 | 248 | 332 | 291 |
| Accrued Expenses | 298 | 365 | 391 | 429 | 377 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 488 | 0 | 0 | 0 | 499 |
| Other Current Liabilities, Total | 304 | 309 | 275 | 332 | 323 |
| Total Liabilities | 3833 | 3495 | 4470 | 4477 | 4379 |
| Total Long Term Debt | 1672 | 1679 | 1687 | 1695 | 1241 |
| Long Term Debt | 1672 | 1679 | 1687 | 1695 | 1241 |
| Other Liabilities, Total | 893 | 942 | 1869 | 1689 | 1648 |
| Total Equity | 4922 | 5180 | 10593 | 10740 | 10895 |
| Common Stock | 2 | 2 | 2 | 2 | 2 |
| Additional Paid-In Capital | 3914 | 3993 | 8849 | 8938 | 8957 |
| Retained Earnings (Accumulated Deficit) | 4870 | 5055 | 5372 | 5485 | 5632 |
| Treasury Stock - Common | -3872 | -3878 | -3643 | -3702 | -3714 |
| Other Equity, Total | 8 | 8 | 13 | 17 | 18 |
| Total Liabilities & Shareholders’ Equity | 8755 | 8675 | 15063 | 15217 | 15274 |
| Total Common Shares Outstanding | 146 | 146 | 157 | 157 | 157 |
| Preferred Stock - Non Redeemable, Net | 0 | ||||
| Long Term Investments | 224 |
- Anual
- Trimestral
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Ingresos netos/Línea de salida | 428 | 678 | 782 | 990 | 656 | 762 |
| Efectivo de actividades de explotación | 779 | 875 | 1142 | 1051 | 1080 | 545 |
| Efectivo de actividades de explotación | 90 | 110 | 140 | 151 | 156 | 176 |
| Amortization | 51 | 46 | 39 | 37 | 31 | 75 |
| Deferred Taxes | 94 | 81 | -18 | 11 | 117 | -76 |
| Partidas no monetarias | 161 | -235 | 217 | 56 | 47 | -240 |
| Cash Taxes Paid | 60 | 149 | 99 | 164 | 119 | 233 |
| Cambios en el capital circulante | -45 | 195 | -18 | -194 | 73 | -152 |
| Efectivo de actividades de inversión | -515 | -214 | -1813 | 745 | -554 | -1069 |
| Gastos de capital | -271 | -312 | -296 | -209 | -189 | -208 |
| Otras partidas de flujo de caja de inversión, total | -244 | 98 | -1517 | 954 | -365 | -861 |
| Efectivo procedente de actividades de financiación | -296 | -176 | 594 | -897 | -766 | -51 |
| Elementos de flujo de caja de financiación | -33 | 8 | 18 | -82 | -91 | -582 |
| Emisión (retiro) de acciones, neto | -202 | -180 | -155 | -265 | -675 | 60 |
| Emisión (amortización) de deuda, neta | -61 | -4 | 731 | -550 | 0 | 471 |
| Efectos del cambio de divisas | -2 | 5 | -4 | -1 | 8 | -3 |
| Variación neta de la tesorería | -34 | 490 | -81 | 898 | -232 | -578 |
| Apr 2021 | Jul 2021 | Oct 2021 | Jan 2022 | Apr 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | 147 | 333 | 650 | 762 | 86 |
| Cash From Operating Activities | 282 | 535 | 263 | 545 | 172 |
| Cash From Operating Activities | 41 | 82 | 128 | 176 | 50 |
| Amortization | 7 | 15 | 34 | 75 | 41 |
| Deferred Taxes | -79 | -156 | -81 | -76 | -21 |
| Non-Cash Items | 104 | 167 | -301 | -240 | 81 |
| Changes in Working Capital | 62 | 94 | -167 | -152 | -65 |
| Cash From Investing Activities | 1376 | 1379 | -1069 | -1069 | -74 |
| Capital Expenditures | -42 | -86 | -138 | -208 | -61 |
| Other Investing Cash Flow Items, Total | 1418 | 1465 | -931 | -861 | -13 |
| Cash From Financing Activities | 968 | 472 | 78 | -51 | 21 |
| Financing Cash Flow Items | -24 | -30 | -452 | -582 | -12 |
| Issuance (Retirement) of Stock, Net | 31 | 31 | 59 | 60 | 33 |
| Issuance (Retirement) of Debt, Net | 961 | 471 | 471 | 471 | 0 |
| Foreign Exchange Effects | -3 | 0 | -2 | -3 | 0 |
| Net Change in Cash | 2623 | 2386 | -730 | -578 | 119 |
| Nombre del Inversor | Tipo de inversor | Porcentaje pendiente | Acciones en propiedad | Cambio de acciones | Fechas de holding | Índice de rotación |
|---|---|---|---|---|---|---|
| Baillie Gifford & Co. | Investment Advisor | 10.6441 | 16743103 | -2276998 | 2022-12-31 | LOW |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 8.1155 | 12765729 | 181808 | 2022-09-30 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 5.0067 | 7875617 | -70812 | 2022-09-30 | LOW |
| Edgewood Management LLC | Investment Advisor/Hedge Fund | 4.7216 | 7427083 | -741779 | 2022-09-30 | LOW |
| State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 4.1761 | 6569010 | 87320 | 2022-09-30 | LOW |
| Polen Capital Management, LLC | Investment Advisor/Hedge Fund | 2.8744 | 4521397 | 1731169 | 2022-09-30 | LOW |
| Loomis, Sayles & Company, L.P. | Investment Advisor/Hedge Fund | 2.2875 | 3598290 | -133808 | 2022-09-30 | LOW |
| Wellington Management Company, LLP | Investment Advisor/Hedge Fund | 2.1278 | 3347008 | 794245 | 2022-09-30 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.7894 | 2814723 | 62313 | 2022-09-30 | LOW |
| Invesco Capital Management (QQQ Trust) | Investment Advisor | 1.2947 | 2036588 | -61824 | 2023-01-31 | LOW |
| Morgan Stanley Investment Management Inc. (US) | Investment Advisor/Hedge Fund | 1.224 | 1925400 | 809753 | 2022-09-30 | LOW |
| Walter Scott & Partners Ltd. | Investment Advisor/Hedge Fund | 1.1659 | 1833973 | -210485 | 2022-09-30 | LOW |
| Two Sigma Investments, LP | Hedge Fund | 1.1614 | 1826869 | 138559 | 2022-09-30 | HIGH |
| Janus Henderson Investors | Investment Advisor/Hedge Fund | 1.1278 | 1773989 | 181237 | 2022-09-30 | LOW |
| Nuveen LLC | Pension Fund | 1.0671 | 1678559 | 29844 | 2022-09-30 | LOW |
| Veritas Asset Management LLP | Investment Advisor/Hedge Fund | 1.0116 | 1591247 | 27792 | 2022-09-30 | LOW |
| AllianceBernstein L.P. | Investment Advisor/Hedge Fund | 1.001 | 1574624 | 671475 | 2022-09-30 | LOW |
| Select Equity Group, L.P. | Investment Advisor/Hedge Fund | 0.9924 | 1561013 | 109439 | 2022-09-30 | LOW |
| BlackRock Asset Management Ireland Limited | Investment Advisor | 0.9053 | 1424051 | 1354 | 2022-09-30 | LOW |
| Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 0.8901 | 1400076 | 2726 | 2021-12-31 | LOW |
¿Por qué operar con Capital.com? Nuestros números hablan por nosotros
Capital.com Group +500000+
Traders
93000+
Clientes activos mensualmente
$57000000+
Volumen mensual de inversión
$31000000+
Pruébalo ahora Retiros por mes
Calculadora de trading
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
Comisión de la operación
0
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
Apalancamiento
20:1
- 20
- 100
- 500
- 1000
- 10000
Inversión
Tamaño de la operación (Apalancamiento x Inversión)
Apertura
Cierre
En corto En largo
Illumina Company profile
Sobre Illumina, Inc.
ILLUMINA, INC. ofrece soluciones basadas en matrices y secuenciadas para el análisis genético. Los productos y servicios de la Compañía atienden a clientes en una variedad de mercados, lo que permite la adopción de soluciones genómicas en investigación y entornos clínicos. Los clientes de la Compañía incluyen centros de investigación genómica, instituciones académicas, laboratorios y hospitales oficiales, así como también compañías farmacéuticas, de biotecnología, agrigenómica y laboratorios comerciales de diagnóstico molecular, y genómica de consumo. Brinda soluciones de muestra para respuesta a sus clientes en diversas áreas de la genómica traslacional y clínica, como la salud reproductiva y genética, y la oncología. Ofrece soluciones de salud reproductiva, como diagnóstico y cribado genético preimplantacional, prueba prenatal no invasiva y pruebas de salud neonatal y genética. También brinda servicios de secuenciación del genoma completo, genotipado y prueba prenatal no invasiva (Noninvasive Prenatal Testing, NIPT). Tiene operaciones en los Estados Unidos, Europa, Asia-Pacífico y otros mercados.
- IndustriaAdvanced Medical Equipment
- Dirección5200 Illumina Way, SAN DIEGO, CA, United States (USA)
- Empleados9800
- CEOFrancis deSouza
| Industry: | Advanced Medical Equipment & Technology (NEC) |
5200 Illumina Way
SAN DIEGO
CALIFORNIA 92122
US
Cuenta de resultados
- Annual
- Quarterly
A la gente también le interesa
¿Aún estás buscando un bróker de confianza?
Únete a más de 500.000 traders de todo el mundo que eligen operar con Capital.com